GSA CAPITAL PARTNERS LLP - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q1 2016$60,000
-28.6%
13,326
-16.3%
0.00%0.0%
Q4 2015$84,000
+7.7%
15,926
+18.2%
0.00%0.0%
Q3 2015$78,000
-80.6%
13,472
-76.1%
0.00%
-73.3%
Q2 2015$403,000
+150.3%
56,300
+132.6%
0.02%
+150.0%
Q1 2015$161,000
-54.5%
24,201
-59.0%
0.01%
-76.0%
Q4 2014$354,000
+21.6%
58,9680.0%0.02%
+66.7%
Q3 2014$291,000
+5.1%
58,968
-4.1%
0.02%
+25.0%
Q2 2014$277,000
-0.7%
61,518
-0.7%
0.01%
-40.0%
Q1 2014$279,000
-2.1%
61,950
+11.2%
0.02%
-13.0%
Q4 2013$285,000
+25.0%
55,695
+10.5%
0.02%
+27.8%
Q3 2013$228,000
-20.8%
50,395
-10.5%
0.02%
-47.1%
Q2 2013$288,00056,2950.03%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders